Scholarlink

Background <p>Febrile neutropenia (FN) is a life-threatening complication in cancer patients that include serious infections with different microorganisms. Unfortunately, resistant pathogens rapidly progressed over the last two decades with a direct impact on survival and health of FN patients. we tried to study the prevalence of bacterial resistance at different infection sites in these patients.</p> Patients and methods <p>This was a retrospective observational cohort study to assess prevalence of bacterial resistance in 1257 patients with neutropenic fever and positive cultures from different sites of infections, admitted to the Medical Oncology intensive care unit (ICU) at national cancer institute (NCI), Egypt, from May 2021 to May 2023.</p> Results <p>One thousand two hundred fifty-seven patients were included, total number of detected organisms was 2221, 1895 were bacterial organisms, most of these isolates were extensively drug-resistant (XDR) gram-negative (57.9%) followed by methicillin resistant coagulase negative staphylococci MR_CONS (18.6%) and multidrug resistant (MDR) gram-negative (14.9%), with emergence of pan-drug resistant (PDR) gram-negative bacteria (2.4%).</p> Conclusion <p>Resistant bacteria are now predominant in patients with neutropenic fever especially with gram-negative bacteria being commonly XDR with an emergence of PDR organisms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of bacterial resistance in critically ill patients with neutropenic fever at National Cancer Institute of Egypt

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月2日

查看全文
  • Ahmed El Sayed,
  • Yasser Ahmed Salam,
  • Ahmed Samir El Sayed El Basiony,
  • Sayed Gaber

摘要

Background

Febrile neutropenia (FN) is a life-threatening complication in cancer patients that include serious infections with different microorganisms. Unfortunately, resistant pathogens rapidly progressed over the last two decades with a direct impact on survival and health of FN patients. we tried to study the prevalence of bacterial resistance at different infection sites in these patients.

Patients and methods

This was a retrospective observational cohort study to assess prevalence of bacterial resistance in 1257 patients with neutropenic fever and positive cultures from different sites of infections, admitted to the Medical Oncology intensive care unit (ICU) at national cancer institute (NCI), Egypt, from May 2021 to May 2023.

Results

One thousand two hundred fifty-seven patients were included, total number of detected organisms was 2221, 1895 were bacterial organisms, most of these isolates were extensively drug-resistant (XDR) gram-negative (57.9%) followed by methicillin resistant coagulase negative staphylococci MR_CONS (18.6%) and multidrug resistant (MDR) gram-negative (14.9%), with emergence of pan-drug resistant (PDR) gram-negative bacteria (2.4%).

Conclusion

Resistant bacteria are now predominant in patients with neutropenic fever especially with gram-negative bacteria being commonly XDR with an emergence of PDR organisms.